I
INMB
Inmune Bio Inc
1.240
+0.030+2.48%Opening10:25 04/06 EDT
OPEN/PREV CLOSE1.300/1.270
TODAY RANGE1.265-1.320
VOL1.40K
MARKET CAP34.29M
52 WEEK RANGE1.090-11.64
AVG VOL (3M)440.25K
% TURNOVER1.39%
TURNOVER0
P/E (TTM)-0.6953
% RANGE4.33%
EPS(TTM)-1.8553
P/E(FORWARD)-1.7315
P/B1.458
BVPS0.8849
DIVIDEND--
P/S678.95
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP28.40M
SHARES OUTSTANDING26.59M
NEXT EARNINGS05/06-05/11
FREE FLOAT22.02M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·04/01 00:26
Inmune Bio Earnings Call Balances Progress and Risk
Dow Jones·03/30 20:04
*INmune Bio 2025 Loss/Shr $1.86 >INMB
Dow Jones·03/30 20:04
*INmune Bio 2025 Loss $45.9M >INMB
Benzinga·03/30 20:02
INmune Bio Q4 EPS $(0.18) Beats $(0.24) Estimate
Reuters·03/30 20:02
INmune Bio FY25 net loss widens to $45.9 million; revenue rises to $50,000
Seeking Alpha·03/30 20:02
INmune Bio GAAP EPS of -$1.86 misses by $0.11, revenue of $0.05M misses by $0.01M
Dow Jones·03/30 20:01
*INmune Bio Estimates Cash on Hand Provides Runway Through 1Q of 2027 >INMB
Reuters·03/30 20:00
INMUNE BIO INC. ANNOUNCES 2025 RESULTS AND PROVIDES BUSINESS UPDATE
Dow Jones·03/30 20:00
Press Release: INmune Bio Inc. Announces 2025 Results and Provides Business Update
Dow Jones·03/30 20:00
Press Release: INmune Bio Inc. Announces 2025 -3-
Seeking Alpha·03/30 14:00
Here are the major earnings after the close Monday
Benzinga·03/30 11:11
Earnings Scheduled For March 30, 2026
Seeking Alpha·03/29 21:35
INmune Bio FY 2025 Earnings Preview
Seeking Alpha·03/29 13:30
Quant snapshot: J. Jill, AngioDynamics leads strong buys as INmune Bio, Terrestrial Energy lag
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.